Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Amgen Inc (4332)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,761.00 0.00    0.00%
11/02 - Closed. Currency in HKD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 1,761.00 / 0.00
  • Day's Range: 1,761.00 - 1,761.00
Type:  Equity
Market:  Hong Kong
ISIN:  US0311621009 
Amgen 1,761.00 0.00 0.00%

4332 Balance Sheet

 
Featured here, the Balance Sheet for Amgen Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/09
2022
30/06
2022
31/03
2021
31/12
Total Current Assets 24062 19322 18520 19385
Cash and Short Term Investments 11478 7183 6544 8037
Cash - - - -
Cash & Equivalents 9502 5203 6528 7989
Short Term Investments 1976 1980 16 48
Total Receivables, Net 5326 5327 5077 5839
Accounts Receivables - Trade, Net 5326 5327 5077 4895
Total Inventory 4757 4554 4411 4086
Prepaid Expenses - - - 1223
Other Current Assets, Total 2501 2258 2488 200
Total Assets 63700 59294 59196 61165
Property/Plant/Equipment, Total - Net 5188 5158 5142 5750
Property/Plant/Equipment, Total - Gross 14388 14158 14042 14548
Accumulated Depreciation, Total -9200 -9000 -8900 -8798
Goodwill, Net 14845 14865 14897 14890
Intangibles, Net 13266 13927 14567 15182
Long Term Investments 874 979 1137 4503
Note Receivable - Long Term - - - 944
Other Long Term Assets, Total 5465 5043 4933 1455
Other Assets, Total 3908 3465 1838 -1505
Total Current Liabilities 14331 12618 12886 12184
Accounts Payable 1204 1256 1403 1366
Payable/Accrued - - - -
Accrued Expenses 11584 10545 10639 8260
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 1543 817 844 232
Other Current liabilities, Total - - - 2326
Total Liabilities 60047 56875 58280 54465
Total Long Term Debt 37161 35705 36010 33222
Long Term Debt 37161 35705 36010 33222
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 8555 8552 9384 9059
Total Equity 3653 2419 916 6700
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 32371 31343 31247 32096
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) -28066 -28252 -29568 -24600
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -652 -672 -763 -796
Total Liabilities & Shareholders' Equity 63700 59294 59196 61165
Total Common Shares Outstanding 533.5 534.9 534.2 558.3
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AMGN Comments

Write your thoughts about Amgen Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email